Lahore: Ferozsons Laboratories Limited has scheduled a board meeting to deliberate on its annual budget for the financial year 2025-26, the company announced on Saturday. The meeting, set to take place on July 10, 2025, will be conducted via video link, a method increasingly adopted by firms to accommodate remote participation.

The company has also declared a "Closed Period" from July 8 to July 10, 2025, in compliance with Regulation 5.6.4 of the Pakistan Stock Exchange (PSX). This period prohibits directors, executives, and any other insiders from trading in the company's shares to prevent any potential misuse of undisclosed financial information.

According to information available from the Pakistan Stock Exchange (PSX), Ferozsons Laboratories Limited is a prominent entity within the healthcare sector, a market category that includes pharmaceutical companies and medical service providers. Such meetings are crucial for aligning financial strategies with the company’s long-term objectives and ensuring transparency in its operations.

The board meeting is a routine corporate governance practice aimed at reviewing and approving the budget, which serves as a financial road map for decision-making and resource allocation for the upcoming fiscal year. The outcome of this meeting is likely to influence the company’s operational focus and strategic initiatives in the healthcare domain.